Third Security’s PTC Therapeutics PTCT Stock Holding History

Third Security’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-109,601	Closed	-$5.19M	–	15
2021 Q1	$5.19M	Sell	109,601 -127,414	-54%	-$7.57M	0.7%	4
2020 Q4	$14.5M	Sell	237,015 -18,858	-7%	-$1.11M	1.32%	4
2020 Q3	$12M	Hold	255,873	–	–	2.48%	4
2020 Q2	$13M	Buy	255,873 +118,322	+86%	+$5.81M	2.15%	5
2020 Q1	$6.14M	Hold	137,551	–	–	1.32%	5
2019 Q4	$6.61M	Hold	137,551	–	–	1.07%	6
2019 Q3	$4.65M	Hold	137,551	–	–	0.7%	7
2019 Q2	$6.19M	Hold	137,551	–	–	0.73%	6
2019 Q1	$5.18M	Hold	137,551	–	–	0.77%	6
2018 Q4	$4.72M	Hold	137,551	–	–	0.64%	7
2018 Q3	$6.46M	Buy	+137,551	New	+$5.69M	0.42%	7

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Third Security's PTCT Position: Q2 2021 in Review

Third Security sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 109,601 shares — an estimated $5.19M sold.

Third Security first reported a position in PTCT in Q3 2018 and held it in 11 quarters. The position peaked at $14.5M in Q4 2020. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

Third Security reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
Third Security sold 109,601 PTC Therapeutics shares in Q2 2021, an estimated $5.19M.
Third Security first reported a position in PTC Therapeutics in Q3 2018 and held it in 11 quarters.
Third Security's PTC Therapeutics position peaked at $14.5M in Q4 2020.
182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Third Security's 13F filing for Q2 2021, filed 12 Aug 2021.